Search

Search Criteria

Products meeting the search criteria

Sort By:  
BOLDENONE UNDECYLENATE 250 MG 10 CC VIAL 1 UNITS EQUIPOISE BLACK DRAGON (excluded of 20 USD Postage fee/order)
highly anabolic and moderately androgenic and is not considered to be toxic to the live
75.00 USD
127.00 USD
BREMELANOTIDE 10 MG 1 UNITS PT-141 UNCHAINED COMPOUNDS (excluded of 20 USD Postage fee/order)
PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone.
112.00 USD
BREMELANOTIDE 10 MG x 3 vial 1 UNITS PT-141 MEDITECH (excluded of 20 USD Postage fee/order)
PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone.
140.00 USD
BRINZOLAMIDE & BRIMONIDINE TARTATE EYE DROP (10 MG 2 MG)/ML (5 ML) 1 UNITS SIMBRINZA NOVARTIS ALCON (excluded of 20 USD Postage fee/order)
Decrease of elevated IOP in adults w/ open-angle glaucoma or ocular HTN for whom monotherapy provides insufficient IOP reduction
26.70 USD
SALE

BOLDENONE UNDECYLENATE 250 MG 10 CC VIAL 1 UNITS EQUIPOISE BLACK DRAGON (excluded of 20 USD Postage fee/order) (EQUIPOISE)

highly anabolic and moderately androgenic and is not considered to be toxic to the live
75.00 USD
127.00 USD

BREMELANOTIDE 10 MG 1 UNITS PT-141 UNCHAINED COMPOUNDS (excluded of 20 USD Postage fee/order) (PT-141)

PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone.
112.00 USD

BREMELANOTIDE 10 MG x 3 vial 1 UNITS PT-141 MEDITECH (excluded of 20 USD Postage fee/order) (PT-141)

PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone.
140.00 USD

BRINZOLAMIDE & BRIMONIDINE TARTATE EYE DROP (10 MG 2 MG)/ML (5 ML) 1 UNITS SIMBRINZA NOVARTIS ALCON (excluded of 20 USD Postage fee/order) (SIMBRINZA)

Decrease of elevated IOP in adults w/ open-angle glaucoma or ocular HTN for whom monotherapy provides insufficient IOP reduction
26.70 USD
Jinimed © 2026Powered By  AbanteCart